DVA Financial Statements | Balance Sheet, Income & Cash Flow Analysis
The financial statements for DVA (DVA) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| BIO Bio-Rad Laboratories, Inc. | $292.23 +1.41% |
| A Agilent Technologies, Inc. | $120.40 +2.47% |
| ALGN Align Technology, Inc. | $184.69 +2.23% |
| MOH Molina Healthcare, Inc. | $147.64 -1.56% |
| BMRN BioMarin Pharmaceutical Inc. | $55.47 +1.08% |
| UHS Universal Health Services, Inc. | $181.95 -0.68% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| BIO Bio-Rad Laboratories, Inc. | $292.23 | +1.41% | 7.89 B | 10.50 | 27.84 | 0.00% | Hold | 198 |
| A Agilent Technologies, Inc. | $120.40 | +2.47% | 34.05 B | 26.58 | 4.53 | 0.84% | Buy | 1.81 |
| ALGN Align Technology, Inc. | $184.69 | +2.23% | 13.23 B | 32.75 | 5.64 | 0.00% | Buy | 768 |
| MOH Molina Healthcare, Inc. | $147.64 | -1.56% | 7.69 B | 16.55 | 8.92 | 0.00% | Hold | 508 |
| BMRN BioMarin Pharmaceutical Inc. | $55.47 | +1.08% | 10.67 B | 30.82 | 1.80 | 0.00% | Buy | 1.56 |
| UHS Universal Health Services, Inc. | $181.95 | -0.68% | 11.57 B | 7.88 | 23.10 | 0.44% | Hold | 400 |
Frequently Asked Questions
What are DVA's latest financial results?
Review DVA's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has DVA's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is DVA's cash flow situation and liquidity?
Cash flow statements reveal how DVA generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does DVA's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether DVA is outperforming or lagging within its sector.
Are DVA's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether DVA's profits are repeatable and supported by strong fundamentals.